Although there are only about 700 new diagnoses of testicular cancer in Australia each year, it is the second most common cancer in young men. As testicular cancer has a very good cure rate (over 95%), there are increasing numbers of survivors … Continue reading
Why do health differences based on social identities arise and endure? And how does this impact on the ways that men cope with cancer-related fertility issues?
Andrology Australia has a catalogue of fact sheets on a wide range of male health topics, and recently we updated three fact sheets about the penis and testes.
A recent study showed that active surveillance for clinical stage 1 testicular cancer leads to excellent outcomes.
Ideally, all adolescents (along with their parents or guardians) and young men who are going to have chemotherapy, radiotherapy or orchidectomy should have a discussion with their doctor about fertility, before treatment begins.
The Movember Foundation invites suitably qualified and experienced research teams to express their interest in participating in an exciting, new global initiative to investigate the drivers and treatments for relapsing germ cell tumour in men who have received frontline therapy.
Research review: Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma
This study aimed to increase the accuracy of risk estimates for second malignancies and mortality associated with adjuvant radiotherapy after surgery for stage 1 seminoma, by assessing outcomes in a group of patients treated as young adults in the UK and Norway.
Cancer Australia with Andrology Australia are developing a Testicular Cancer Data Set Specification The aim of this project is to develop data standards to assist clinical monitoring and reporting of the treatment and care received by males affected by testicular … Continue reading
Andrology Australia announces the release of a new fact sheet: "Fertility preservation for adolescent and young adult males"